Denosumab at Least Equal to Alendronate at Increasing BMD

BOSTON — The investigational antiresorptive denosumab is at least as effective as alendronate for increasing bone mineral density in postmenopausal women, Dr. Nelson Watts said at the annual meeting of the Endocrine Society.